Development of a novel therapeutic vaccine carrier that sustains high antibody titers against several targets simultaneously
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of a novel therapeutic vaccine carrier that sustains high antibody titers against several targets simultaneously
Authors
Keywords
-
Journal
FASEB JOURNAL
Volume 31, Issue 3, Pages 1204-1214
Publisher
FASEB
Online
2016-12-20
DOI
10.1096/fj.201600820r
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Malaria vaccines and human immune responses
- (2016) Carole A Long et al. CURRENT OPINION IN MICROBIOLOGY
- Development of a schistosomiasis vaccine
- (2016) Adebayo J. Molehin et al. Expert Review of Vaccines
- The effect of preexisting anti-carrier immunity on subsequent responses to CRM197or Qb-VLP conjugate vaccines
- (2016) Michael J. McCluskie et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Development of an Interleukin-1β Vaccine in Patients with Type 2 Diabetes
- (2016) Claudia Cavelti-Weder et al. MOLECULAR THERAPY
- Vaccines targeting self-antigens: mechanisms and efficacy-determining parameters
- (2015) Falk Saupe et al. FASEB JOURNAL
- Vaccination against IL-33 Inhibits Airway Hyperresponsiveness and Inflammation in a House Dust Mite Model of Asthma
- (2015) Ying Lei et al. PLoS One
- Therapeutic vaccination against fibronectin ED-A attenuates progression of metastatic breast cancer
- (2015) Julia Femel et al. Oncotarget
- Unraveling galectin-1 as a novel therapeutic target for cancer
- (2013) Lucile Astorgues-Xerri et al. CANCER TREATMENT REVIEWS
- Targeting IL-23 by employing a p40 peptide-based vaccine ameliorates murine allergic skin and airway inflammation
- (2012) Q. Guan et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Vaccination against trypanosomiasis
- (2011) Florencia La Greca et al. Human vaccines & immunotherapeutics
- The non-toxic and biodegradable adjuvant Montanide ISA 720/CpG can replace Freund's in a cancer vaccine targeting ED-B—a prerequisite for clinical development
- (2011) Elisabeth J.M. Huijbers et al. VACCINE
- Vaccination against the extra domain-B of fibronectin as a novel tumor therapy
- (2010) Elisabeth J. M. Huijbers et al. FASEB JOURNAL
- A comparative analysis of oncofetal fibronectin and tenascin-C incorporation in tumour vessels using human recombinant SIP format antibodies
- (2010) Alexander Berndt et al. HISTOCHEMISTRY AND CELL BIOLOGY
- Versatile Virus-Like Particle Carrier for Epitope Based Vaccines
- (2010) Alain C. Tissot et al. PLoS One
- A Recombinant Vaccine Effectively Induces C5a-Specific Neutralizing Antibodies and Prevents Arthritis
- (2010) Kutty Selva Nandakumar et al. PLoS One
- Carrier induced epitopic suppression of antibody responses induced by virus-like particles is a dynamic phenomenon caused by carrier-specific antibodies
- (2010) Andrea Jegerlehner et al. VACCINE
- Fibronectins in vascular morphogenesis
- (2009) Sophie Astrof et al. ANGIOGENESIS
- Identification of potent biodegradable adjuvants that efficiently break self-tolerance—A key issue in the development of therapeutic vaccines
- (2009) Maria Ringvall et al. VACCINE
- Therapeutic vaccines against IgE-mediated allergies
- (2008) Lars Hellman Expert Review of Vaccines
- Structure and specificity of lamprey monoclonal antibodies
- (2008) B. R. Herrin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started